Publish Audited Results
Marksans Pharma Ltd has informed BSE that the Company will publish Annual Audited Results for the year ended March 31, 2011 before May 30, 2011. Therefore, unaudited financial results for the quarter ended on March 31, 2011 will not be published or given to Stock Exchanges. Outcome of Board Meeting
Marksans Pharma Ltd has informed BSE that in terms of the provisions of Section 262 of the CompaniesAct, 1956 and the Articles of Association of the Company, the Board of Directors of the Company has, at its meeting held May 02, 2011, appointed Mr. Ajoy S. Joshi as a Director (non-executive and independent) of the Company to fill the casual vacancy caused by the resignation of Mr. Kumar Nair effective from May 02, 2011. Limited Review for the quarter ended Dec 31, 2010
Marksans Pharma Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2010. Financial Results for Dec 31, 2010
Marksans Pharma Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010. Change of Registered Office
Marksans Pharma Ltd has informed BSE that the Registered Office of the Company has changed from 21st Floor, Lotus Business park, Off New Link Road, Andheri (W), Mumbai - 400053 to 11th Floor, Lotus Business Park, Off New Link Road, Andheri (W), Mumbai - 400053 with effect from December 14, 2010. Limited Review for the quarter ended Sep 30, 2010
Marksans Pharma Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2010. Financial Results for Sep 30, 2010
Marksans Pharma Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2010. Resignation of Director
Marksans Pharma Ltd has informed BSE that Mr. Kumar Nair has resigned as a Director Of the company effective from November 02, 2010. Outcome of AGM
Marksans Pharma Ltd has informed BSE that the members at the 18th Annual General Meeting (AGM) of the Company held on September 28, 2010, inter alia, have passed the following resolutions: 1. Adoption of the Audited Balance Sheet as at March 31, 2010 & the Profit and Loss Account for the period ended March 31, 2010 and the Reports of the Directors and the Auditors thereon together with all annexures and schedules mentioned therein.... Fixes Book Closure for AGM
Marksans Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2010 to September 28, 2010 (both days inclusive) for the purpose of 18th Annual General Meeting (AGM) of the Company to be held on September 28, 2010.